More than two years after the passage of the Inflation Reduction Act (“IRA”) and the Centers for Medicare and Medicaid Services’ (“CMS’”) ...
A new study examining the use of high-cost drugs among patients with colorectal cancer and non-small cell lung cancer found ...
If you’re looking for an OTC medication that’ll ease pain and quell inflammation, there are several great options to choose ...
Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...
A study comparing oral glucose-lowering agents to insulin for gestational diabetes found no non-inferiority in preventing ...
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...